BioMarin Pharmaceutical | BMRN - 부채에 대한이자 비용





부채에 대한이자 비용 변화 날짜
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Amgen USD 657M 4M 2026-03
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Gilead Sciences USD 240M 15M 2026-03
Incyte USD 569K 13K 2026-03
Insmed USD 20.08M 517K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Moderna USD 11.49B 36B 2026-03
Neurocrine Biosciences USD 1.1M 0 2024-03
PTC Therapeutics USD 2.87B 2.82B 2026-03
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sanofi EUR -25M 99.78M 2025-12
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
Ultragenyx Pharmaceutical USD 21M 2M 2026-03
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12